PERSEUS-IT (NCT02289924) was a prospective, observational, 2-year study evaluating the effectiveness and treatment patterns of intravitreal aflibercept (IVT-AFL) in patients with neovascular age-related macular degeneration (nAMD) in routine clinical practice in Italy.
Nicolò, M., Ciucci, F., Nardi, M., Parolini, B., Russo, A., Scupola, A., et al. (2022). PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration. GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1-11 [10.1007/s00417-022-05679-6].
PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration
Vadala', MariaUltimo
2022-05-05
Abstract
PERSEUS-IT (NCT02289924) was a prospective, observational, 2-year study evaluating the effectiveness and treatment patterns of intravitreal aflibercept (IVT-AFL) in patients with neovascular age-related macular degeneration (nAMD) in routine clinical practice in Italy.
| File | Dimensione | Formato | |
|---|---|---|---|
|
PERSEUS-IT 2022.pdf
accesso aperto
Descrizione: Articolo
Tipologia:
Versione Editoriale
Dimensione
995.52 kB
Formato
Adobe PDF
|
995.52 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
